Lipocalin 2 enhances mesenchymal stem cell-based cell therapy in acute kidney injury rat model

Acute kidney injury (AKI) is one of the most common health-threatening diseases in the world. There is still no effective medical treatment for AKI. Recently, Mesenchymal stem cell (MSC)-based therapy has been proposed for treatment of AKI. However, the microenvironment of damaged kidney tissue is n...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cytotechnology
Päätekijät: Roudkenar, Mehryar Habibi, Halabian, Raheleh, Tehrani, Hossein Abdul, Amiri, Fatemeh, Jahanian-Najafabadi, Ali, Roushandeh, Amaneh Mohammadi, Abbasi-Malati, Zahra, kuwahara, Yoshikazu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Netherlands 2017
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5809639/
https://ncbi.nlm.nih.gov/pubmed/28573544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-017-0107-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia